Literature DB >> 4110894

The eosinophil and allergy: why?

R W Honsinger, D Silverstein, P P Van Arsdel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4110894     DOI： 10.1016/0091-6749(72)90108-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  5 in total

1.  Glycomacropeptide administration attenuates airway inflammation and remodeling associated to allergic asthma in rat.

Authors:  Nuria Renata Roldán; Mariela Jiménez; Daniel Cervantes-García; Estefanía Marín; Eva Salinas
Journal:  Inflamm Res       Date:  2016-01-11       Impact factor: 4.575

2.  [Experimental allergic chorioretinitis in rabbits by immunization to homologous retina in adjuvant. II. Histological studies (author's transl)].

Authors:  S Tilgner; E Hempel; W Meyer; K D Schröder
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1974

3.  [Immunoglobulin E. Biochemical, immunological properties and clinical significance (author's transl)].

Authors:  R Lamerz; A Fateh-Moghadam
Journal:  Klin Wochenschr       Date:  1974-01-01

4.  Eosinophilic leukaemia: morphological, cytochemical, and electron microscopic studies.

Authors:  B Presentey; Z Jerushalmy; U Mintz
Journal:  J Clin Pathol       Date:  1979-03       Impact factor: 3.411

5.  Role of interleukin-23 in the development of nonallergic eosinophilic inflammation in a murine model of asthma.

Authors:  Hyun Seung Lee; Da-Eun Park; Ji-Won Lee; Kyung Hee Sohn; Sang-Heon Cho; Heung-Woo Park
Journal:  Exp Mol Med       Date:  2020-01-20       Impact factor: 8.718
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.